Safety and Immunogenicity of a Single Dose of Intranasal Seasonal Trivalent Live-Attenuated Influenza Vaccine

NCT01625689 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
309
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

PATH Vaccine Solutions

Collaborators